Kite Pharma Inc. buy melinda
Start price
02.04.16
/
50%
€44.22
Target price
08.08.16
€57.73
Performance (%)
19.54%
End price
08.08.16
€52.86
Summary
This prediction ended on 08.08.16 with a price of €52.86. The prediction had a final performance of 19.54%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Kite Pharma Inc. | - | - | - | - |
iShares Core DAX® | 1.560% | 2.566% | 18.261% | 16.927% |
iShares Nasdaq 100 | 0.517% | 1.894% | 25.521% | 35.441% |
iShares Nikkei 225® | 1.730% | 5.631% | 18.569% | 13.063% |
iShares S&P 500 | 1.482% | 1.594% | 24.989% | 38.339% |
Comments by melinda for this prediction
In the thread Kite Pharma Inc. diskutieren
Stier
Kite Pharma, Inc. betreibt als klinisches Praktikum Biotechnologie - Unternehmen, qui in der Entwicklung und Vermarktung neuartiger Krebs immunotherapeutic Produkte mit Fokus auf technisch autologe T - Zell - Therapeutika beschäftigt Gezielte , um verschiedene Arten von Tumor.
(Vom Mitglied beendet)
Stopped prediction by melinda for Kite Pharma Inc.
Kite Pharma Inc.
Start price
Target price
Perf. (%)
€160.57
31.08.17
31.08.17
€166.87
05.10.17
05.10.17
0.99%
05.10.17
05.10.17